1 |
Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood[J]. Blood, 2010, 116(16): e74-e80.
|
2 |
Heine GH, Ortiz A, Massy ZA, et al. Monocyte subpopulations and cardiovascular risk in chronic kidney disease[J]. Nat Rev Nephrol, 2012, 8(6): 362-369.
|
3 |
Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update[J]. Arterioscler Thromb Vasc Biol, 2008, 28(11): 1897-1908.
|
4 |
Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques[J]. J Clin Invest, 2007, 117(1): 185-194.
|
5 |
Flierl U, Schäfer A. Fractalkine: a local inflammatory marker aggravating platelet activation at the vulnerable plaque[J]. Thromb Haemost, 2012, 108(3): 457-463.
|
6 |
Flierl U, Bauersachs J, Schäfer A. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3CL1) in cardiovascular disease[J]. Eur J Clin Investig, 2015, 45(6): 624-633.
|
7 |
Schlitt A, Heine GH, Blankenberg S, et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels[J]. Thromb Haemost, 2004, 92(2): 419-424.
|
8 |
Heine GH, Ulrich C, Seibert E, et al. CD14+CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients[J]. Kidney Int, 2008, 73(5): 622-629.
|
9 |
邹春霞, 王小庆, 杨大浩. 急性ST段抬高型心肌梗死患者HbA1c、单核细胞亚群检测及预后评估[J]. 海南医学, 2019, 30(14): 1769-1772.
|